Rabin Medical Center: Communicable Diseases trials

The registry lists 10 Communicable Diseases studies with Rabin Medical Center as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 4Phase 4 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Intra-wound Vancomycin Powder for Prevention of Surgical Site Infection Following Spinal SurgeryRecruitingNCT05959603Phase 3
• Fixed-dose Amikacin for Elderly UTIStatus unknownNCT04197739Phase 4
• High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori InfectionStatus unknownNCT02553083Phase 4
• Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During PregnancyCompletedNCT02351102Phase 2/3
• Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa InfectionStatus unknownNCT02102152Not applicable
• Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract InfectionWithdrawnNCT02034890Phase 4
• Optimal Antibiotic Treatment of Moderate to Severe Bacterial InfectionsCompletedNCT01338116Not applicable
• Epidemiology of Infections in Pediatric Cancer PatientsStatus unknownNCT00934115
• Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus InfectionsCompletedNCT00427076Phase 3
• Computerized Decision Support System for Antibiotic TreatmentCompletedNCT00233376Phase 3